Target intelligence / Profile preview

Microtubule (Tubulin beta chain)

Molecular classification
Cytoskeletal protein, Structural protein, GTP-binding protein
01

Overview

Microtubules are dynamic cytoskeletal polymers composed of alpha- and beta-tubulin heterodimers that are essential for maintaining cell shape, facilitating intracellular transport, and forming the mitotic spindle during cell division (Jordan & Wilson, 2004). In oncology, microtubules are the direct target of the taxane component within chemotherapy regimens such as TPC (Taxane, Platinum, and Cyclophosphamide or Cetuximab), which is frequently utilized in the treatment of ovarian, breast, and lung cancers (National Cancer Institute). Taxanes, including paclitaxel and docetaxel, bind specifically to the beta-tubulin subunit on the inner surface of the microtubule, promoting assembly and suppressing the dynamic instability required for chromosome segregation (PubChem). This stabilization results in the formation of non-functional microtubule bundles, leading to cell cycle arrest at the G2/M phase and the induction of apoptosis (StatPearls). While highly effective, targeting microtubules with taxanes is often associated with dose-limiting toxicities such as peripheral neuropathy and neutropenia (FDA).

Other names
TubulinBeta-tubulinMitotic spindleMicrotubule polymerTubulin beta-1 chain
02

Mechanism of action

Taxanes bind to the interior surface of the microtubule specifically at the beta-tubulin subunit, which stabilizes the microtubule polymer and protects it from disassembly. This inhibition of depolymerization disrupts the dynamic instability required for mitotic spindle function, leading to cell cycle arrest at the G2/M phase and subsequent apoptosis.

03

Biological functions

Cell cycleCell divisionIntracellular transportCell motilityStructural integrityMitotic spindle formation
04

Disease associations

CancerOvarian cancerBreast cancerNon-small cell lung cancerProstate cancerHead and neck cancer
05

Safety considerations

Peripheral neuropathyNeutropeniaMyelosuppressionHypersensitivity reactionsAlopeciaCardiotoxicity (rare)
06

Interacting drugs

Paclitaxel

3 more in the full profile.

07

Biomarkers

TUBB3 (Class III beta-tubulin expression)MAPT (Tau protein expression)STMN1 (Stathmin expression)TJP1 (Tight junction protein 1)

Beyond the preview

Go deeper on Microtubule (Tubulin beta chain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule (Tubulin beta chain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call